KRYSTAL BIOTECH INC COM is a security (CUSIP 501147102) tracked across SEC portfolio filings. 409 institutional managers reported $7.2B on Form 13F as of 2026-06-30; 33 registered fund positions totaling $673.4M via N-PORT as of 2026-05-31.
Showing 15 of 409 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| FMR LLC | BOSTON, MA | $1.1B | 4,373,987 |
| BlackRock, Inc. | New York, NY | $1.0B | 3,940,456 |
| Avoro Capital Advisors LLC | New York, NY | $746.3M | 2,888,888 |
| VANGUARD GROUP INC | Valley Forge, PA | $685.1M | 2,778,845 |
| STATE STREET CORP | BOSTON, MA | $339.5M | 1,314,434 |
| Soleus Capital Management, L.P. | GREENWICH, CT | $297.9M | 1,153,087 |
| Capital World Investors | LOS ANGELES, CA | $213.0M | 824,720 |
| Redmile Group, LLC | San Francisco, CA | $174.0M | 673,505 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $166.4M | 643,975 |
| Hood River Capital Management LLC | PALM BEACH GARDENS, FL | $160.1M | 619,586 |
| Bellevue Group AG | Kuesnacht, V8 | $124.5M | 481,785 |
| Frazier Life Sciences Management, L.P. | MENLO PARK, CA | $124.3M | 481,307 |
| DIMENSIONAL FUND ADVISORS LP | AUSTIN, TX | $121.1M | 468,990 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | CHICAGO, IL | $105.2M | 407,178 |
| FIRST TRUST ADVISORS LP | Wheaton, IL | $90.5M | 350,521 |
Showing 15 of 33 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| Fidelity Growth Company Fund | Fidelity Mt. Vernon Street Trust | $243.7M | 24.67% |
| SMALLCAP World Fund Inc | SMALLCAP World Fund Inc | $194.3M | 23.98% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $74.5M | 9.14% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $70.6M | 64.85% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $39.4M | 22.45% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $10.4M | 21.58% |
| Fidelity Capital Appreciation Fund | Fidelity Capital Trust | $5.0M | 6.57% |
| abrdn Healthcare Investors | abrdn Healthcare Investors | $4.8M | 42.54% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $4.4M | 66.21% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $3.8M | 0.65% |
| BNY Mellon Smallcap Stock Index Fund | BNY MELLON INDEX FUNDS, INC. | $3.4M | 39.81% |
| VANGUARD U.S. MOMENTUM FACTOR ETF | VANGUARD WELLINGTON FUND | $3.3M | 17.83% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $3.2M | 1.07% |
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $3.0M | 52.65% |
| Optimum Small-Mid Cap Growth Fund | Optimum Fund Trust | $2.6M | 34.81% |